認知症・高齢診療科

Medicine & Life Sciences

1. Alzheimer Disease 96%
2. Dementia 78%
3. Cognition 50%
4. Cognitive Dysfunction 43%
5. Japan 35%
6. Amyloid 24%
7. Memory 24%
8. Caregivers 23%
9. Mental Status and Dementia Tests 23%
10. hemoglobin Chad 22%
11. Behavioral Symptoms 19%
12. Meta-Analysis 19%
13. Systematic Reviews 19%
14. (2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine 18%
15. Waist Circumference 17%
16. Hyperproinsulinemia 16%
17. Safety 15%
18. Renal Dialysis 15%
19. Diabetes Mellitus 14%
20. Hemadsorption 13%
21. Geriatrics 13%
22. Randomized Controlled Trials 13%
23. Inservice Training 13%
24. Neuroimaging 12%
25. Brain 12%
26. Proinsulin 11%
27. Glycogen Synthase Kinase 3 11%
28. Multimorbidity 11%
29. Amyloidogenic Proteins 11%
30. Psychology 11%
31. tau Proteins 10%
32. Independent Living 10%
33. Cellulose 10%
34. Cost of Illness 10%
35. Cholinesterase Inhibitors 10%
36. Immunoassay 9%
37. Insulin 9%
38. Leisure Activities 9%
39. NP 031112 8%
40. Middle Aged 8%
41. Education 8%
42. Cross-Sectional Studies 8%
43. Mental Competency 8%
44. Long-Term Care Insurance 8%
45. Drinking 7%
46. Short-Term Memory 7%
47. Cluster Analysis 7%
48. Activities of Daily Living 7%
49. Regression Analysis 7%
50. Neuropsychological Tests 7%
51. Volunteers 7%
52. Elderly 7%
53. Hemoglobins 6%
54. Placebos 6%
55. Alcohols 6%
56. Interviews 6%
57. Insulin Antibodies 6%
58. Magnetic Resonance Imaging 5%
59. Depression 5%
60. Social Support 5%
61. Wechsler Scales 5%
62. Costs and Cost Analysis 5%
63. Kidney 5%
64. Delivery of Health Care 5%

Social Sciences

1. dementia 100%
2. cognitive impairment 31%
3. Japan 21%
4. caregiver 16%
5. cognition 14%
6. cluster analysis 8%
7. complaint 8%
8. mental state 7%
9. Group 7%
10. brain 7%
11. Healthcare 6%
12. hypertension 6%
13. human being 6%
14. regression analysis 5%
15. long-term care insurance 5%
16. resources 5%